Women's Heart: Impact of Ultra-endurance and Hormonal Profile on Cardiac and Systemic Inflammatory Parameters in Female Runners

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorFrench Cardiology Society

About this trial

The goal of this clinical trial is to describe the cardiac and systemic inflammatory adaptations specific to women practicing ultra-endurance sports.

The objectives are to:

* Improve the understanding of cardiac and systemic inflammatory adaptations specific to women participating in ultra-endurance sports. * Assess the relationship between observed cardiac and systemic inflammatory alterations and the relative levels of estrogen, testosterone, and progesterone. * Describe the vascular adaptations specific to women participating in ultra-endurance sports. * Examine the influence of defense mechanisms on the emotional dynamics observed during and after an ultra-endurance race.

Eligibility criteria

Qualifiers

Must have a Global Positioning System watch during the race;

"Ecotrail de Paris Ile France©" (=a trail running race in the Paris region, it is not possible to translate; it is a registered trademark) 80 kilometers;

Or "la 6000D©" 69 kilometers;

Medical certificate stating no contraindications to competitive running, dated less than 12 months prior to the race;

Disqualifiers

Refusal or linguistic or mental incapacity to sign the informed consent form;

Person under guardianship (conservatorship, curators, or legal protection) or deprived of liberty;

Person not affiliated with a social security scheme;

Pregnant woman;

Trial design

Treatments tested in this trial

  • Echocardiography
  • Arterial ultrasound
  • Blood sampling
  • Scales and questionnaire
  • Vital signs
  • Urinary test

Treatment groups

120 Participants
are divided into 1 treatment group

Sponsors and collaborators